Davenport & CO LLC Merck & Co., Inc. Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 285,734 shares of MRK stock, worth $29.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

285,734

Previous 278,037 2.77%

Holding current value

$29.1 Million

Previous $34.4 Million 5.73%

% of portfolio

0.19%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $855,521 - $992,682	7,697 Added 2.77%	285,734 $32.4 Million
Q2 2024 Aug 06, 2024	SELL	$123.8 - $132.96 $635,589 - $682,616	-5,134 Reduced 1.81%	278,037 $34.4 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $628,029 - $731,794	-5,546 Reduced 1.92%	283,171 $37.4 Million
Q4 2023 Jan 23, 2024	BUY	$100.18 - $109.02 $106,491 - $115,888	1,063 Added 0.37%	288,717 $31.5 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $77,418 - $85,976	-752 Reduced 0.26%	287,654 $29.6 Million
Q2 2023 Jul 20, 2023	SELL	$108.61 - $118.38 $3.89 Million - $4.24 Million	-35,817 Reduced 11.05%	288,406 $33.3 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $3.35 Million - $3.74 Million	-32,526 Reduced 9.12%	324,223 $34.5 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $2.28 Million - $2.92 Million	-26,047 Reduced 6.8%	356,749 $0
Q3 2022 Oct 11, 2022	SELL	$84.53 - $94.96 $20,118 - $22,600	-238 Reduced 0.06%	382,796 $33 Million
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $24,546 - $27,824	294 Added 0.08%	383,034 $34.9 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $304,037 - $340,806	4,136 Added 1.09%	382,740 $31.4 Million
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $585,395 - $733,283	-8,099 Reduced 2.09%	378,604 $29 Million
Q3 2021 Oct 14, 2021	BUY	$71.68 - $78.83 $5.03 Million - $5.53 Million	70,184 Added 22.17%	386,703 $29 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $3.17 Million - $3.51 Million	45,109 Added 16.62%	316,519 $24.6 Million
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $132,830 - $156,461	1,929 Added 0.72%	271,410 $20.9 Million
Q4 2020 Jan 13, 2021	SELL	$71.77 - $79.65 $41.2 Million - $45.7 Million	-573,651 Reduced 68.04%	269,481 $22 Million
Q3 2020 Oct 15, 2020	SELL	$73.18 - $82.95 $2.41 Million - $2.73 Million	-32,889 Reduced 3.75%	843,132 $69.9 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $42.5 Million - $48.4 Million	-603,981 Reduced 40.81%	876,021 $67.7 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $1.34 Million - $1.86 Million	-21,155 Reduced 1.41%	1,480,002 $114 Million
Q4 2019 Jan 22, 2020	SELL	$77.58 - $87.54 $18.6 Million - $21 Million	-240,227 Reduced 13.8%	1,501,157 $137 Million
Q3 2019 Oct 16, 2019	SELL	$76.08 - $82.93 $7.2 Million - $7.85 Million	-94,675 Reduced 5.16%	1,741,384 $146 Million
Q2 2019 Jul 10, 2019	SELL	$69.84 - $81.59 $1.26 Million - $1.48 Million	-18,098 Reduced 0.98%	1,836,059 $154 Million
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $497,218 - $567,106	-7,146 Reduced 0.38%	1,854,157 $154 Million
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $1.49 Million - $1.73 Million	-22,845 Reduced 1.21%	1,861,303 $142 Million
Q3 2018 Oct 11, 2018	SELL	$57.69 - $67.84 $1.1 Million - $1.29 Million	-19,016 Reduced 1.0%	1,884,148 $134 Million
Q2 2018 Jul 09, 2018	SELL	$50.83 - $59.72 $329,225 - $386,806	-6,477 Reduced 0.34%	1,903,164 $116 Million
Q1 2018 Apr 04, 2018	BUY	$50.96 - $59.23 $924,312 - $1.07 Million	18,138 Added 0.96%	1,909,641 $104 Billion
Q4 2017 Jan 17, 2018	SELL	$51.62 - $61.64 $594,662 - $710,092	-11,520 Reduced 0.61%	1,891,503 $106 Billion
Q3 2017 Oct 12, 2017	BUY	$58.67 - $63.13 $112 Million - $120 Million	1,903,023	1,903,023 $122 Billion

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account